Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Teijin Pharma Limited.

https://www.teijin-pharma.com/

Latest From Teijin Pharma Limited.

Synairgen Supercharges R&D With $100m Financing

With a candidate COVID-19 therapy in clinical development, the UK’s Synairgen has raised $101m on the UK’s AIM to support clinical studies and manufacturing plans.

Financing Coronavirus COVID-19

Keeping Track Of Breakthroughs: AZ Farxiga, ImmunoGen ADC For Hematologic Cancer, Inventiva NASH Candidate Earn Designation

The latest breakthrough therapy designation news and highlights from the Pink Sheet’s US FDA Performance Tracker.

Review Pathway Cancer

GSK’s Emma Walmsley Made A Dame In UK Honors

Walmsley has been awarded a damehood in the Queen’s Birthday Honours List. Meanwhile, Synairgen co-founder Holgate is to become a Sir.

Companies Research & Development

Changing Of The Guard At Merck KGaA With Garijo Succeeding Oschmann As CEO

The appointment of Belén Garijo as CEO of the German major from May next year is a small but significant step on the road to addressing gender inequality at the very top level of management in the world of big pharma.

Appointments Leadership
See All

Company Information

  • Industry
  • Medical Devices
    • Rehabilitation Equipment and Devices
  • Other Names / Subsidiaries
    • MedTech Heart
UsernamePublicRestriction

Register